Nephros (FRA:NPJP) Change In Payables And Accrued Expense : €-0.25 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Nephros Change In Payables And Accrued Expense?

Nephros's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was €0.00 Mil. It means Nephros's Accounts Payable & Accrued Expense increased by €0.00 Mil from Dec. 2024 to Mar. 2025 .

Nephros's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €-0.43 Mil. It means Nephros's Accounts Payable & Accrued Expense declined by €0.43 Mil from Dec. 2023 to Dec. 2024 .

Nephros Change In Payables And Accrued Expense Historical Data

The historical data trend for Nephros's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Change In Payables And Accrued Expense Chart

Nephros Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.27

1.05

-0.70

0.59

-0.43

Nephros Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.13	0.06	-0.79	0.48	-

Nephros Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.25 Mil.

Nephros Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Nephros's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nephros Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

NEPH:USA

Address

380 Lackawanna Place, South Orange, NJ, USA, 07079

Website

https://www.nephros.com

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Nephros Headlines

No Headlines